Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
Episodic ataxia type 1 (EA1) is an autosomal dominant neurological disorder characterized by constant muscle rippling movements (myokymia) and episodic attacks of ataxia. Several heterozygous point mutations have been found in the coding sequence of the voltage-gated potassium channel gene KCNA1 (hKv1.1), which alter the delayed-rectifier function of the channel. Shaker-like channels of different cell types may be formed by unique hetero-oligomeric complexes comprising Kv1.1, Kv1.4 and Kvbeta1.x subunits. Here we show that the human Kvbeta1.1 and Kvbeta1.2 subunits modulated the functional properties of tandemly linked Kv1.4-1.1 wild-type channels expressed in Xenopus laevis oocytes by (i) increasing the rate and amount of N-type inactivation, (ii) slowing the recovery rate from inactivation, (iii) accelerating the cumulative inactivation of the channel and (iv) negatively shifting the voltage dependence of inactivation. To date, the role of the human Kv1.4-1.1, Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2 channels in the aetiopathogenesis of EA1 has not been investigated. Here we also show that the EA1 mutations E325D, V404I and V408A, which line the ion-conducting pore, and I177N, which resides within the S1 segment, alter the fast inactivation and repriming properties of the channels by decreasing both the rate and degree of N-type inactivation and by accelerating the recovery from fast inactivation. Furthermore, the E325D, V404I and I177N mutations shifted the voltage dependence of the steady-state inactivation to more positive potentials. The results demonstrate that the human Kvbeta1.1 and Kvbeta1.2 subunits regulate the proportion of wild-type Kv1.4-1.1 channels that are available to open. Furthermore, EA1 mutations alter heteromeric channel availability which probably modifies the integration properties and firing patterns of neurones controlling cognitive processes and body movements.
Imbrici
Paola
P
University of Perugia School of Medicine, Department of Internal Medicine, Section of Human Physiology, Via del Giochetto, I-06126 Perugia, Italy.
D'Adamo
Maria Cristina
MC
Kullmann
Dimitri M
DM
Pessia
Mauro
M
D000200:Action Potentials / Q000235:genetics; D000818:Animals; D002490:Central Nervous System / Q000378:metabolism* / Q000503:physiopathology; D003071:Cognition / Q000502:physiology; D005260:Female; D006801:Humans; D015640:Ion Channel Gating / Q000235:genetics; D051662:Kv1.1 Potassium Channel / Q000235:genetics*; D051663:Kv1.2 Potassium Channel / Q000235:genetics; D051665:Kv1.4 Potassium Channel / Q000235:genetics*; D008958:Models, Molecular; D009068:Movement / Q000502:physiology; D009154:Mutation / Q000235:genetics*; D020385:Myokymia / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D009865:Oocytes; D021122:Protein Subunits / Q000235:genetics; D013132:Spinocerebellar Degenerations / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D014982:Xenopus laevis
C496946:KCNA1 protein, human; C496977:KCNA4 protein, human; D051663:Kv1.2 Potassium Channel; D051665:Kv1.4 Potassium Channel; D021122:Protein Subunits; D051662:Kv1.1 Potassium Channel